Pzena Investment Management LLC Has $152.73 Million Stock Holdings in Cigna Group $CI

Pzena Investment Management LLC increased its stake in Cigna Group (NYSE:CIFree Report) by 1.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 529,841 shares of the health services provider’s stock after acquiring an additional 6,241 shares during the quarter. Pzena Investment Management LLC owned about 0.20% of Cigna Group worth $152,727,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in CI. Harbor Capital Advisors Inc. lifted its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the period. Solstein Capital LLC bought a new position in Cigna Group during the second quarter worth $29,000. Chilton Capital Management LLC acquired a new position in Cigna Group in the second quarter valued at $30,000. Princeton Global Asset Management LLC boosted its position in Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 52 shares during the last quarter. Finally, Collier Financial bought a new stake in Cigna Group during the third quarter valued at $34,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Price Performance

Shares of NYSE:CI opened at $290.24 on Thursday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The stock’s 50 day moving average is $278.52 and its 200-day moving average is $283.99. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $77.53 billion, a price-to-earnings ratio of 13.09, a PEG ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter last year, the firm posted $6.64 EPS. Cigna Group’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is currently 27.23%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CI shares. Guggenheim reissued a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Cantor Fitzgerald cut their price target on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Truist Financial increased their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $330.63.

Check Out Our Latest Stock Report on CI

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.